The Fed has held its funds rate at 3.50%-3.75% through all of 2026 — zero cuts — and Goldman Sachs now doesn't expect one until 2027. That's the short answer. The longer answer is that startup valuations went up anyway, and the reason why says more about the 2026 market than the rate decision itself.
Heading into 2026, the consensus trade was simple: inflation cools, the Fed cuts three or four times, the cost of capital falls, and growth valuations re-rate higher across the board. None of that happened on schedule. Inflation came in hotter, the Fed stayed on hold, and the 10-year Treasury climbed instead of falling. Yet Series A pre-money valuations are up 9.6% year-over-year and VC firms deployed $412.7B in the first half of 2026 alone. We track both sides of this trade daily, and the disconnect is the single most important macro story founders and LPs are getting wrong right now.
Figures blended from Federal Reserve H.15 releases, FRED DGS10 Treasury data, Goldman Sachs rate forecasts, and the Q2 2026 PitchBook-NVCA Venture Monitor. Fed and Treasury figures reflect data as of July 10, 2026.
Fed Rate Cuts and Startup Valuations in 2026: What Actually Happened
The Fed kept its target range at 3.50%-3.75% at its June 2026 meeting and is expected to hold again at the July 28-29, 2026 meeting, according to the Federal Reserve's own H.15 release and FOMC guidance. That's zero cuts through the first seven months of the year, against a market that entered 2026 pricing in three to four. Core PCE inflation was revised sharply higher — to 3.6% for 2026 and 3.3% for 2027, up from earlier 2.7% projections — which is the specific reason the Fed has stayed on hold rather than easing.
Goldman Sachs now expects no cuts at all until 2027, a meaningful pushback from the bank's own earlier forecast. The 10-year Treasury yield, which sets the discount rate used to value future startup cash flows, closed at 4.49% on July 2 and 4.56% on July 10, 2026 — well above the 3.8-4.0% range many forecasters expected by midyear. Higher yields mean a lower present value for the same projected revenue, which is the textbook mechanism by which rates are supposed to compress private-market multiples.
The 2026 Macro Setup: Expectation vs. Reality
| Metric | Early-2026 Consensus | Actual as of July 2026 | Source |
|---|---|---|---|
| Fed funds rate | 3-4 cuts to ~2.75-3.00% | Held at 3.50-3.75% | Federal Reserve H.15 |
| First rate cut timing | Q1-Q2 2026 | Pushed to 2027 | Goldman Sachs |
| 10-year Treasury yield | Drifting to ~3.8-4.0% | 4.56% (July 10) | FRED DGS10 |
| Core PCE inflation | ~2.7% | Revised to 3.6% | Fed staff forecasts |
| H1 VC capital deployed | Modest recovery | $412.7B, 86% to AI | PitchBook-NVCA Q2 2026 |
| Series A pre-money valuation | Flat to modest growth | $49.3M, +9.6% YoY | PitchBook |
| Series B pre-money valuation | Flat | $118.9M, up from $102.8M | PitchBook |
Figures are 2026 estimates blended from Federal Reserve H.15 releases, FRED, Goldman Sachs rate forecasts, and the Q2 2026 PitchBook-NVCA Venture Monitor. "Early-2026 consensus" reflects widely cited forecaster and market-implied expectations as of January 2026.
Why Startup Valuations Rose Anyway: AI Concentration, Not Cheap Capital
VC firms deployed $412.7B globally in H1 2026, with megadeals of $100M or more capturing 87.5% of that total. AI accounted for 86% of all venture dollars deployed. Venture-growth capital alone hit $274.2B through May — already more than double the full-year 2025 total — but 86.4% of that figure traces back to just four rounds from three foundation-model companies. This is not a broad-based valuation recovery; it's an extremely narrow one concentrated in a handful of AI mega-rounds that would happen at almost any interest rate.
Capital concentration at the fund level is compounding the effect. Three firms — Andreessen Horowitz, Thrive Capital, and Founders Fund — took in 48.1% of all capital raised by VC funds in the period, while first-time fund formation is on pace for its lowest year since 2016. Meanwhile roughly 50% of total VC dry powder now sits in vehicles between two and five years old, close to the record 54.4% share seen the prior quarter — a level that even exceeds dry-powder buildup after the 2008 financial crisis and the dot-com bust. Managers are sitting on capital they're not deploying broadly, then writing enormous checks into a small number of AI outliers.
That combination — narrow AI concentration plus fund-level capital concentration — is doing the work that lower rates were supposed to do, but only for a small slice of the market. You can see the split clearly in Series A data: pre-money valuations recovered from a 2023 trough of roughly $30M to $40M-$80M in 2026, but that's still below the $80M-$100M peaks of late 2021, and it's an average that hides an AI premium of 2-4x versus non-AI sectors. Our VC performance dashboard breaks out fund-level returns by vintage so you can see how concentrated the current cycle really is relative to prior ones.
How Interest Rates Are Still Compressing the Rest of the Market
Outside the AI mega-round headlines, the higher-for-longer rate environment is doing exactly what the textbook predicts. Private SaaS multiples are tracking at 4-8x ARR in 2026, versus 15-20x in 2021 — a direct consequence of a 10-year Treasury sitting at 4.56% instead of near zero, since the discount rate applied to a company's future cash flows has roughly tripled. Round sizes and valuations across the broader market remain 30-50% below 2021 peaks, and that gap has not meaningfully closed despite two-plus years of "recovery" narratives.
AI companies are the exception, not the rule: AI and ML companies command roughly 3-5x higher revenue multiples than traditional SaaS peers, which is scarcity pricing on top of genuinely differentiated growth, not a market-wide re-rating. If you strip AI mega-rounds out of the H1 2026 venture data, the remaining 14% of dollars deployed across every other sector looks far closer to what a "higher for longer" rate regime would predict — cautious, selective, and priced at a real discount to 2021.
For founders outside AI, this matters enormously when you benchmark your own round. Anchoring to a headline valuation number that's being pulled upward by a handful of AI foundation-model deals will set the wrong target. Check your own metrics against the SaaS valuations dashboard rather than against a media narrative built on outlier rounds.
There's a second-order effect worth flagging too: growth-stage debt got more expensive alongside the Treasury move, not less. Venture debt pricing is typically quoted as a spread over a benchmark rate, so a 10-year sitting at 4.56% instead of 3.5% or lower pushes the all-in cost of a debt tranche up by roughly a full point even before lenders widen spreads for risk. Companies that layered venture debt into a Series A or B to manage dilution in 2026 are paying more for that leverage than they would have under the rate path most forecasters expected in January — another quiet cost of the cuts that never came.
Where H1 2026 Venture Capital Actually Went
Q2 2026 PitchBook-NVCA Venture Monitor
When Will the Fed Actually Cut, and What Happens to Startup Valuations If It Does
The Fed's own guidance is that easing will be gradual and contingent on inflation moving sustainably toward its 2% target — a target the current 3.6% PCE reading is well above. With Goldman Sachs now modeling no cuts until 2027, founders and LPs should plan around a rate environment that stays roughly where it is for another two to four quarters at minimum, not the aggressive easing path that was consensus a year ago.
If cuts do arrive in 2027, the mechanical effect should be a lower discount rate and, all else equal, higher multiples across the broader market — the part of venture that hasn't participated in the AI re-rating. That would be a genuinely different story than 2026, where the valuation gains are almost entirely explained by capital concentration in a small number of AI rounds rather than a falling cost of capital. Early-stage activity is still historically strong on a deal-count basis — first financings are on track to exceed 7,000 in 2026, a new record by more than 1,300 deals — which suggests the underlying company-formation engine is healthy even while pricing stays bifurcated.
The practical read for LPs and fund managers: don't model 2027 distributions on the assumption that a rate cut alone reflates the broader portfolio. With roughly half of all VC dry powder still sitting in two-to-five-year-old vehicles and first-time fund formation on pace for its weakest year since 2016, the capital that's supposed to chase a re-rating is either concentrated with the largest managers or sitting uncalled. A cut would help at the margin, but it wouldn't undo the structural concentration that's defined this cycle — that requires either a broadening of AI winners beyond the current handful of foundation-model companies or a genuine rotation of capital back into non-AI sectors, neither of which is showing up in the data yet.
Bottom line: The Fed rate cuts that were supposed to be the 2026 macro tailwind for startup valuations never showed up — the funds rate has sat at 3.50%-3.75% all year and Goldman Sachs now doesn't expect relief until 2027. Valuations rose anyway, but only where AI concentration created scarcity: 86% of $412.7B in H1 2026 venture dollars went to AI, and three firms took in 48.1% of new fund capital. Everywhere else, the math is behaving exactly as higher rates predict — SaaS multiples at 4-8x ARR versus 15-20x in 2021, and round sizes still 30-50% below the 2021 peak. Know which market you're actually in before you benchmark your round against this year's headlines.
Get VC data most people never see — free.
Weekly benchmarks, valuations, and fund data. No spam, unsubscribe anytime.